Ads
related to: Enbrel- Is RINVOQ Right For You?
RINVOQ® Could Be Right For You.
See RINVOQ® Clinical Trial Results.
- Watch Video
What Is RINVOQ®?
Watch A Video To Learn More.
- Treatment Didn't Help?
Looking To Change Treatments?
RINVOQ® Could Be The Right Fit.
- Register For More Info
Sign Up For More
Information About RINVOQ®.
- RINVOQ® Complete
Get Access To Prescription Savings
And Insurance Coverage Info.
- What Is RINVOQ®?
Learn About The FDA-Approved
Oral Pill.
- Is RINVOQ Right For You?
Search results
Sigma Planning Corp Has $1.85 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 4 days agoSigma Planning Corp decreased its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 65.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and ...
Greenleaf Trust Increases Position in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 3 days agoGreenleaf Trust increased its stake in Biogen Inc. (NASDAQ:BIIB – Free Report) by 20.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission ...
UBS Group Trims Amgen (NASDAQ:AMGN) Target Price to $284.00
ETF DAILY NEWS· 7 days agoAmgen (NASDAQ:AMGN – Free Report) had its price objective trimmed by UBS Group from $314.00 to $284.00 in a research note released on Wednesday morning, Benzinga reports. The brokerage currently ...
Biogen (BIIB) Scheduled to Post Quarterly Earnings on Wednesday
ETF DAILY NEWS· 5 days agoBiogen (NASDAQ:BIIB – Get Free Report) will be announcing its earnings results before the market opens on Wednesday, April 24th. Analysts expect the company to announce earnings of $3.48 per ...
Biogen Inc. (NASDAQ:BIIB) to Post Q3 2024 Earnings of $4.13 Per Share, Wedbush Forecasts
ETF DAILY NEWS· 7 days agoBiogen Inc. (NASDAQ:BIIB – Free Report) – Investment analysts at Wedbush raised their Q3 2024 earnings estimates for Biogen in a research note issued to investors on Wednesday, April 17th. Wedbush ...
Sumitomo Mitsui DS Asset Management Company Ltd Has $4.59 Million Stock Position in Biogen Inc....
ETF DAILY NEWS· 3 days agoSumitomo Mitsui DS Asset Management Company Ltd lessened its holdings in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 0.4% during the 4th quarter, according to the company in its most ...
Federated Hermes Inc. Decreases Stock Position in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 4 days agoFederated Hermes Inc. lessened its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 4.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities ...
Desjardins Global Asset Management Inc. Has $115,000 Holdings in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 6 days agoDesjardins Global Asset Management Inc. cut its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 86.0% in the 4th quarter, according to its most recent Form 13F filing with the ...
Oppenheimer Lowers Biogen (NASDAQ:BIIB) Price Target to $270.00
ETF DAILY NEWS· 6 days agoBiogen (NASDAQ:BIIB – Get Free Report) had its price objective dropped by equities researchers at Oppenheimer from $290.00 to $270.00 in a research note issued on Friday, Benzinga reports. The ...
Ads
related to: Enbrel